drugset / Trial / NCT02233023
Ophthalmologic Safety of Long Term Treatment With Pramipexole Compared to Bromocriptine or Other Dopamine Agonists in Patients With Parkinson's Disease
Non-randomizedParallel-groupOpen-labelTreatment
Summary
Study to assess and compare the safety of long term oral treatment for Parkinson's Disease with pramipexole versus bromocriptine or other dopamine agonists, by measuring cross-sectional the incidence of ophthalmologic disturbances, especially signs of retinal degeneration, in a matched pair design
Timeline
- Start
- 1998-06
- Primary completion
- 2000-06
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Bromocriptine | Small molecule | — | Oral |
| Subject | Pramipexole | Unknown | — | Oral |